Sunstar has already launched a pro-biotic lozenge called PerioBalance and is already Sinclair’s partner for Aloclair, the patented mouth ulcer gel and mouth rinse, marketed in the Americas under the names GUM Canker-X and GUM Rincinol.
The new licence agreement encompasses the launch of the Decapinol OTC oral rinse under the GUM brand.
The new agreement also gives Sunstar an option to license Decapinol for the Japanese market once the product is registered there, and an option to several other countries where the product is currently not marketed.
The product will be marketed through pharmacies and other retailers across the US to appeal to the health conscious consumer.
Sinclair commercial chief scientific officer Simon Youlton said with Sinclair’s delmopinol based alternative to antiseptic mouth rinses and their own PerioBalance lozenge, Sunstar is well placed to leverage this transition to a healthier, natural approach to daily oral care and has the marketing presence to convey this message.
Sinclair CEO Chris Spooner said they chose to initiate negotiations with Sunstar for the commercialisation of Decapinol, as they had already managed to build the brand for Aloclair in the US.
Sunstar business management officer Tom Studney said they are delighted to secure the Decapinol license, for the treatment and prevention of periodontal disease, for the US and expand their successful partnership with Sinclair.
The product’s launch in the US is planned for 2011.